Chemoinformaics analysis of (ENT)-PIMARA-8(14),15-DIEN-19-OIC-ACID
Molecular Weight | 318.457 | nRot | 2 |
Heavy Atom Molecular Weight | 288.217 | nRig | 18 |
Exact Molecular Weight | 318.219 | nRing | 3 |
Solubility: LogS | -3.953 | nHRing | 0 |
Solubility: LogP | 3.171 | No. of Aliphatic Rings | 3 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 55.8098 |
nHD | 2 | BPOL | 30.9642 |
QED | 0.751 |
Synth | 4.592 |
Natural Product Likeliness | 3.448 |
NR-PPAR-gamma | 0.92 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.032 |
CACO-2 | -5.044 |
MDCK | 0.0000197 |
BBB | 0.921 |
PPB | 0.901813 |
VDSS | 0.582 |
FU | 0.102637 |
CYP1A2-inh | 0.009 |
CYP1A2-sub | 0.504 |
CYP2c19-inh | 0.015 |
CYP2c19-sub | 0.722 |
CYP2c9-inh | 0.065 |
CYP2c9-sub | 0.304 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.122 |
CYP3a4-inh | 0.571 |
CYP3a4-sub | 0.17 |
CL | 0.828 |
T12 | 0.13 |
hERG | 0.003 |
Ames | 0.013 |
ROA | 0.183 |
SkinSen | 0.035 |
Carcinogencity | 0.347 |
EI | 0.354 |
Respiratory | 0.956 |
NR-Aromatase | 0.377 |
Antiviral | No |
Prediction | 0.686648 |